They also found that the transcription factor PITX2 was especially upregulated in bone metastases as compared to soft tissue metastases, and that PITX2 was important for prostate cancer migration stimulated by the non-cononical ligand, Wnt5A [18]. Here, PITX2 is linked to prostate carcinoma.